WCN26-4956 LONG-TERM OUTCOME OF 28 CASES OF DRUG-RESISTANT MINIMAL CHANGE NEPHROTIC SYNDRIME TREATED WITH LDL APHERESIS -RESULT OF A RETROSPECTIVE MULTICENTER SURVEY-

Read full text Summarise with VIRAT
Authors: Eri Muso, Kazuhiko Tsuruya
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Nephrotic syndrome in minimal change nephrotic syndrome(MCNS) is known to be highly responsive to steroid therapy. However, in substantial cases, it does not respond to drugs and sometimes progresses into focal segmental glomerulosclerosis(FSGS) with renal dysfunction. For fFSGS cases, previous studies reported that LDL apheresis treatment in combination with immunosuppressive drugs including steroids and cyclosporine A rapidly yielded a high rate of remission from refractory nephrotic syndrome with hypercholesterolemia.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Systemic Lupus Erythematosus Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105611–105611
Publication date
25 March 2026
Language
EN